BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 20808939)

  • 1. A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
    Hessel A; Schwendinger M; Fritz D; Coulibaly S; Holzer GW; Sabarth N; Kistner O; Wodal W; Kerschbaum A; Savidis-Dacho H; Crowe BA; Kreil TR; Barrett PN; Falkner FG
    PLoS One; 2010 Aug; 5(8):e12217. PubMed ID: 20808939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
    Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
    J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.
    Castrucci MR; Facchini M; Di Mario G; Garulli B; Sciaraffia E; Meola M; Fabiani C; De Marco MA; Cordioli P; Siccardi A; Kawaoka Y; Donatelli I
    Influenza Other Respir Viruses; 2014 May; 8(3):367-75. PubMed ID: 24373385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase.
    Meseda CA; Atukorale V; Soto J; Eichelberger MC; Gao J; Wang W; Weiss CD; Weir JP
    Sci Rep; 2018 Mar; 8(1):5364. PubMed ID: 29599502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity.
    Hessel A; Schwendinger M; Holzer GW; Orlinger KK; Coulibaly S; Savidis-Dacho H; Zips ML; Crowe BA; Kreil TR; Ehrlich HJ; Barrett PN; Falkner FG
    PLoS One; 2011 Jan; 6(1):e16247. PubMed ID: 21283631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
    Kistner O; Crowe BA; Wodal W; Kerschbaum A; Savidis-Dacho H; Sabarth N; Falkner FG; Mayerhofer I; Mundt W; Reiter M; Grillberger L; Tauer C; Graninger M; Sachslehner A; Schwendinger M; Brühl P; Kreil TR; Ehrlich HJ; Barrett PN
    PLoS One; 2010 Feb; 5(2):e9349. PubMed ID: 20186321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.
    Yang S; Niu S; Guo Z; Yuan Y; Xue K; Liu S; Jin H
    Virol J; 2013 Sep; 10():291. PubMed ID: 24053449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus.
    Di Mario G; Soprana E; Gubinelli F; Panigada M; Facchini M; Fabiani C; Garulli B; Basileo M; Cassone A; Siccardi A; Donatelli I; Castrucci MR
    Pathog Glob Health; 2017 Mar; 111(2):69-75. PubMed ID: 28081672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
    Mayrhofer J; Coulibaly S; Hessel A; Holzer GW; Schwendinger M; Brühl P; Gerencer M; Crowe BA; Shuo S; Hong W; Tan YJ; Dietrich B; Sabarth N; Savidis-Dacho H; Kistner O; Barrett PN; Falkner FG
    J Virol; 2009 May; 83(10):5192-203. PubMed ID: 19279103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene.
    Kamlangdee A; Kingstad-Bakke B; Anderson TK; Goldberg TL; Osorio JE
    J Virol; 2014 Nov; 88(22):13300-9. PubMed ID: 25210173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.
    Brewoo JN; Powell TD; Jones JC; Gundlach NA; Young GR; Chu H; Das SC; Partidos CD; Stinchcomb DT; Osorio JE
    Vaccine; 2013 Apr; 31(14):1848-55. PubMed ID: 23376279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.
    Chen GL; Lau YF; Lamirande EW; McCall AW; Subbarao K
    Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1140-5. PubMed ID: 21199945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
    J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.